Highlights
- •Colchicine can prevent attacks of familial Mediterranean Fever (FMF) in most cases
- •Interleukin-1 inhibitors are efficient in FMF patients resistant to colchicine
- •IL-1 inhibitors were frequently prescribed for AA amyloidosis FMF with kidney failure
- •IL-1 inhibitors are useful in case of acquired neoplastic or inflammatory comorbidity
- •IL-1 inhibitor can be withdrawn in FMF patients with AAA after kidney transplantation
Keywords
Abbreviations:
FMF (Familial Mediterranean Fever), AAA (AA Amyloidosis), IL (Interleukin), EULAR (European League Against Rheumatism), FMF-IC (FMF with inflammatory comorbidity)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- EULAR recommendations for the management of familial Mediterranean fever.Ann Rheum Dis. 2016 Apr 1; 75: 644-651
- Colchicine Therapy for Familial Mediterranean Fever.N Engl J Med. 1974; 291 (Oct 31): 934-937
- Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.N Engl J Med. 1986; 314 (Apr 17): 1001-1005
- Pyrin Inflammasome Activation and RhoA Signaling in the Autoinflammatory Diseases FMF and HIDS.Nat Immunol. 2016; 17 (Aug): 914-921
- Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.Arthritis Rheumatol Hoboken NJ. 2017; 69: 854-862
- Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.N Engl J Med. 2018; 378 (17): 1908-1919
- Criteria for the diagnosis of familial Mediterranean fever.Arthritis Rheum. 1997; 40 (Oct): 1879-1885
- Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012; 27 (May): 1898-1901
- Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.Clin Rheumatol. 2016; 35 (Feb): 441-446
- Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.Clin Transplant. 2018; 32 (Aug): e13345
Article info
Publication history
Published online: November 19, 2020
Accepted:
November 2,
2020
Received in revised form:
October 26,
2020
Received:
June 29,
2020
Identification
Copyright
© 2020 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
